Document Detail

The first provocative test for coronary artery spasm at the Cleveland Clinic.
MedLine Citation:
PMID:  20387313     Owner:  NLM     Status:  MEDLINE    
This article provides narration of the events during the development of ergonovine maleate infusions for detecting coronary artery spasm at the Cleveland Clinic in 1973. This was the first safe, reproduceable and reliable test for angiographic visualization of the pathophysiology associated with the Prinzmetal Syndrome termed "angina inversa".
Wayne Siegel
Related Documents :
25206443 - Application of sodium alginate microspheres in ischemic stroke modeling in miniature pigs.
686483 - Angiographic and pathologic correlations in prinzmetal variants angina.
8564003 - Left atrial performance indices in chronic mitral valve disease.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The American journal of cardiology     Volume:  105     ISSN:  1879-1913     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-04-13     Completed Date:  2010-06-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1198-9     Citation Subset:  AIM; IM    
Baptist Hospital, Miami, FL, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angina Pectoris, Variant / diagnosis
Coronary Angiography
Coronary Vasospasm / diagnosis*
Coronary Vessels / drug effects,  physiopathology
Diagnosis, Differential
Ergonovine / administration & dosage,  diagnostic use*
Hospitals, Teaching*
Infusions, Intravenous
Oxytocics / administration & dosage,  diagnostic use
Reproducibility of Results
Reg. No./Substance:
0/Oxytocics; 60-79-7/Ergonovine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Current developments in salivary diagnostics.
Next Document:  Temporary Assistance for Needy Families (TANF) carry-over funds. Final rule.